271 related articles for article (PubMed ID: 37804407)
1. Evaluation of Long Non-coding RNA (LncRNA) in the Pathogenesis of Chemotherapy Resistance in Cervical Cancer: Diagnostic and Prognostic Approach.
Modabber N; Mahboub SS; Khoshravesh S; Karimpour F; Karimi A; Goodarzi V
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37804407
[TBL] [Abstract][Full Text] [Related]
2. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
Yan SP; Chu DX; Qiu HF; Xie Y; Wang CF; Zhang JY; Li WC; Guo RX
J Cell Mol Med; 2019 Apr; 23(4):2656-2666. PubMed ID: 30697971
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of lncRNA-mRNA co-expression networks in HPV-driven cervical cancer reveals the pivotal function of LINC00511-PGK1 in tumorigenesis.
Xin X; Jia-Yin Y; Jun-Yang H; Rui W; Xiong-Ri K; Long-Rui D; Liu J; Jue-Yu Z
Comput Biol Med; 2023 Jun; 159():106943. PubMed ID: 37099974
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancer.
Wen X; Liu S; Sheng J; Cui M
PeerJ; 2020; 8():e9234. PubMed ID: 32523813
[TBL] [Abstract][Full Text] [Related]
5. LncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer.
Feng S; Liu W; Bai X; Pan W; Jia Z; Zhang S; Zhu Y; Tan W
Cancer Lett; 2019 Nov; 465():105-117. PubMed ID: 31499118
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1.
Xu D; Dong P; Xiong Y; Yue J; Konno Y; Ihira K; Kobayashi N; Todo Y; Watari H
Cells; 2020 Mar; 9(3):. PubMed ID: 32151082
[TBL] [Abstract][Full Text] [Related]
8. iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling.
Xiong Y; Sun F; Dong P; Watari H; Yue J; Yu MF; Lan CY; Wang Y; Ma ZB
J Exp Clin Cancer Res; 2017 Apr; 36(1):48. PubMed ID: 28399926
[TBL] [Abstract][Full Text] [Related]
9. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
[TBL] [Abstract][Full Text] [Related]
10. Biological Function of Long Non-coding RNA (LncRNA) Xist.
Wang W; Min L; Qiu X; Wu X; Liu C; Ma J; Zhang D; Zhu L
Front Cell Dev Biol; 2021; 9():645647. PubMed ID: 34178980
[TBL] [Abstract][Full Text] [Related]
11. TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines.
Liu Y; Liu L; Mou ZX
Biochem Genet; 2022 Feb; 60(1):173-190. PubMed ID: 34143331
[TBL] [Abstract][Full Text] [Related]
12. LncRNAs: key players and novel insights into cervical cancer.
Peng L; Yuan X; Jiang B; Tang Z; Li GC
Tumour Biol; 2016 Mar; 37(3):2779-88. PubMed ID: 26715267
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA ZEB1-AS1 promotes cell invasion and epithelial to mesenchymal transition through inducing ZEB1 expression in cervical cancer.
Cheng R; Li N; Yang S; Liu L; Han S
Onco Targets Ther; 2018; 11():7245-7253. PubMed ID: 30425516
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA NORAD upregulate SIP1 expression to promote cell proliferation and invasion in cervical cancer.
Huo H; Tian J; Wang R; Li Y; Qu C; Wang N
Biomed Pharmacother; 2018 Oct; 106():1454-1460. PubMed ID: 30119219
[TBL] [Abstract][Full Text] [Related]
15. LncRNA GHET1 promotes cervical cancer progression through regulating AKT/mTOR and Wnt/β-catenin signaling pathways.
Liu Z; Luo S; Wu M; Huang C; Shi H; Song X
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31682716
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA in cervical cancer: From biology to therapeutic opportunity.
He J; Huang B; Zhang K; Liu M; Xu T
Biomed Pharmacother; 2020 Jul; 127():110209. PubMed ID: 32559848
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.
Heery R; Finn SP; Cuffe S; Gray SG
Cancers (Basel); 2017 Apr; 9(4):. PubMed ID: 28430163
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of lncRNAs microarray profile and mRNA-lncRNA co-expression in oncogenic HPV-positive cervical cancer cell lines.
Yang L; Yi K; Wang H; Zhao Y; Xi M
Oncotarget; 2016 Aug; 7(31):49917-49929. PubMed ID: 27363024
[TBL] [Abstract][Full Text] [Related]
19. Roles of long non-coding RNAs in cervical cancer.
Luo F; Wen Y; Zhou H; Li Z
Life Sci; 2020 Sep; 256():117981. PubMed ID: 32561395
[TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance.
Liu Y; Ao X; Wang Y; Li X; Wang J
Front Oncol; 2022; 12():841411. PubMed ID: 35155266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
